TNFerade

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

TNFerade in Medical News

GenVec Announces Second Quarter 2009 Results Conference Call

...peutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. tnferade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal ca...

GenVec Receives Grant for Malaria Vaccine Program

TNFerade in Medical Technology

GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO

GAITHERSBURG, Md.--(BUSINESS WIRE)--Jun 4, 2007 - GenVec, Inc. (Nasdaq: GNVC) announced today that updated preliminary safety and efficacy data from the clinical development program of its lead product TNFerade(TM) was presented in a poster session on gastrointestinal cancers at the annual meeting ...

TNFerade(TM) Phase III Data Presented at ASCO

...ts) had occurred. The analysis concluded that tnferade appeared to be safe and well-tolerated. The analys...icated a 25% reduction in the risk of death in the tnferade plus standard-of-care (SOC) arm compared to the pa... within approximately 11.8 months. However, in the tnferade plus SOC group, 75% of the patients did not die un...

GenVec Announces New Research at AACR on Selectivity and Mechanism of Action of TNF-Based Anti-Cancer Therapy

...e) is an adenovector, or DNA carrier, which contains the gene for TNF(alpha), a potent immune system protein with well-documented anti-cancer effects. tnferade is currently in a pivotal Phase II/III trial for locally advanced pancreatic cancer. GenVec researchers presented a poster entitled, "Selective deliv...

TNFerade in Biological Technology

GenVec Reports Second Quarter 2009 Financial Results

...by increases related to the manufacturing costs of tnferade arising from the letter agreement and subsequent t... Second Quarter and Recent Highlights tnferade for Cancer As of July 31, 2009, 262 ...tudy (PACT) in locally advanced pancreatic cancer. tnferade has also been and is currently being evaluated for...

GenVec Expands Contract Supporting Malaria Vaccine Program

GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants

Other Tags

Ophthalmic Katena Khosla Minus Adjustable Grafton Classic Mucotome Fresnel Dermatome BANGOLINI Algerbrush Maltzman Dietz

(Date:6/18/2013)... Pomona, Calif. (PRWEB) June 18, 2013 ... associate professor of Family Medicine for the College of ... of Health Sciences has been elected president of the ... Gov. Edmund G. Brown Jr. appointed Connett, a 1984 ... , OMBC members recently elected Connett to the position ...

(Date:6/18/2013)... Lauren Sciences, a privately-held biotechnology company furthering development ... today that it was independently recognized as a ... Platform, and selected as a Featured Company, in ... , The report, " Early Stage Drug Delivery ... features companies MCD Group independently selected as technology ...

(Date:6/18/2013)... Center enrolled their first patients in the ROADSTER Study, ... procedure to help clear blockages in carotid arteries and ... people in the United States are diagnosed with blockages, ... these blockages can slow or even stop blood flow ... known as a "brain attack." , Current treatment ...

(Date:6/18/2013)... are scrambling to gather data for the FDA to ... brain injury in the United States. The University of ... in the Journal of Neurotrauma that it ... instead of one., Jeffrey J. Bazarian, M.D., M.P.H., an ... the first to show that measuring a combination of ...

(Date:6/18/2013)... The world,s first computer guided fitness training system ... of the three winners of the LeWeb,13 London ... , The startup company, Genetrainer, building on ... PhD graduate, Ralph Pethica and Julian Gough, Professor ... Science, was selected from over 350 startups to ...

Breaking Medicine News(10 mins):Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2

[0] WesternU's David Connett Elected OMBC President [0] Lauren Sciences independently recognized as a Technology Innovator in Drug Delivery with its V-Smart™ Platform, and selected as a Featured Company, in new report by MCD Group [0] UH Case Medical Center among first to enroll patients for global carotid artery trial [0] New concussion data: 2 biomarkers better than 1 [0] Podium finish for Genetrainer

(Date:6/18/2013)... DNA and this modification can occur in millions ... scientists believed that this epigenetic phenomenon actively reduced ... of researchers from the University of Geneva (UNIGE), ... the Faculty of Medicine, reveals that this is ... may play both a passive and active role ...

(Date:6/17/2013)... in patients with severe brain infections in Vietnam. Further ... responsible for the symptoms of disease. , The virus ... 644 patients with severe brain infections in the study, ... the 122 patients with non-infectious brain disorders that were ... system are often fatal and patients who do survive, ...

(Date:6/17/2013)... improving original foundations with more modern elements. Using this ... Kenneth P. Dietrich School of Arts and Sciences have ... delivery, gas storage, and gas transport more efficient and ... the latest issue of the Journal of the ... recent work builds upon Pitt Associate Professor of Chemistry ...

Breaking Biology News(10 mins):The secret of DNA methylation 2 New virus isolated from patients with severe brain infections 2 New virus isolated from patients with severe brain infections 3 'Chemical architects' build materials with potential applications in drug delivery and gas storage 2

[0] The secret of DNA methylation [0] New virus isolated from patients with severe brain infections [0] 'Chemical architects' build materials with potential applications in drug delivery and gas storage